Abstract
The effects of 3 lipidosis-inducing drugs on the incorporation and turnover of palmitic acid-1-14C in lung phospholipids was studied.
In rats treated with 1 dose of chlorphentermine or RMI 10.393, the incorporation of palmitate-1-14C into most lung phospholipid fractions was moderately decreased, but markedly lowered after 1 dose of Ro 4-4318.
Eight doses of chlorphentermine and RMI 10.393 strongly inhibited the incorporation of palmitate-1-14C into lung phospholipids, whereas with 8 doses of Ro 4-4318 the incorporation was highly increased.
Thirty hours after the last of 3 injections of the labeled palmitic acid the turnover of most lung phospholipids was considerably lower in chlorphentermine and RMI 10.393-treated rats than in controls. Ro 4-4318, however, induced a highly increased turnover of most phospholipids. After 54 h, this effect had practically disappeared.
Our studies showed that phospholipid storage after treatment with chlorphentermine and RMI 10.393 is mainly due to decreased degradation of phospholipids, whereas increased synthesis accounts for the effect of Ro 4-4318.
Zusammenfassung
An Ratten wurden die Wirkung von 3 Lipidose-erzeugenden Medikamenten auf den Einbau und den Turnover von Palmitinsäure-1-14C in Phospholipiden der Lunge untersucht.
Nach 1 Dosis Chlorphentermin und RMI 10.393 war der Einbau von Palmitinsäure-1-14C in die Lungenphospholipide leicht reduziert. Eine Dosis Ro 4-4318 dagegen führte zu stark vermindertem Palmitateinbau.
Acht Dosen Chlorphentermin und RMI 10.393 hemmten den Einbau von Palmitinsäure in die Lungenphospholipide deutlich. Acht Dosen Ro 4-4318 dagegen steigerten den Einbau von Palmitat in die einzelnen Phospholipidfraktionen.
Dreißig Stunden nach der letzten von 3 Palmitat-Injektionen war der Turnover der meisten Phospholipide in Chlorphentermin und RMI 10.393-behandelten Ratten niedriger als in Kontrollratten. Im Gegensatz dazu erhöhte Ro 4-4318 den Turnover der meisten Lungenphospholipide. Nach 54 Std hatte sich der Phospholipid-Turnover in den Rattenlungen weitgehend normalisiert.
Unsere Untersuchungen zeigten, daß die Phospholipidspeicherung, die durch Chlorphentermin und RMI 10.393 ausgelöst wird, auf einer Hemmung des Phospholipidabbaus zurückgeführt werden kann. Dagegen beruht die Phospholipidose, die durch Ro 4-4318 induziert wird, auf einer Aktivierung der Phospholipidsynthese.
Similar content being viewed by others
References
Buckingham, S., Heinemann, H. O., Sommers, S. C., McNary, W. F.: Phospholipid synthesis in the large pulmonary alveolar cell. Amer. J. Path. 48, 1027–1041 (1966)
Chen, P. S., Toribara, T. Y., Warner, H.: Microdetermination of phosphorus. Anal. Chem. 28, 1756–1758 (1956)
Elsbach, P.: Increased synthesis of phospholipids during phagocytosis. J. clin. Invest. 47, 2217–2229 (1968)
Felts, J. M.: Carbohydrate and lipid metabolism of lung tissue in vitro. Med. thorac. 22, 89–99 (1965)
Folch, J., Lees, M., Stanley, S.: A simple method for the isolation and purification of total lipides from animal tissues. J. biol. Chem. 226, 497–509 (1957)
Harlan, W. R., Said, S. I., Banerjee, C. M.: Metabolism of pulmonary phospholipids in normal lung and during acute pulmonary edema. Amer. Rev. resp. Dis. 94, 938–947 (1966)
Hruban, Z., Slesers, A., Aschenbrenner, J.: Pulmonary intraalveolar histiocytosis induced by drugs. Toxicol. appl. Pharmacol. 26, 72–85 (1973)
Karabelnik, D., Zbinden, G.: Drug-induced foam cell reactions in rats. II. Chemical analysis of lipids stored in lungs and foam cells after treatment with chlorphentermine, 5-[p-(fluoren-9-ylidenemethyl) phenyl]-2-piperidineethanol (RMI 10.393) and 1-chloramitriptyline. Hoppe-Seylers Z. physiol. Chem. 356, 1151–1160 (1975)
Karabelnik, D., Zbinden, G.: Proceedings of the European Society of Toxicology 1975 (1976, in press)
Karabelnik, D., Zbinden, G., Baumgartner, E.: Drug-induced foam cell reactions in rats. I. Histopathologic and cytochemical observations after treatment with chlorphentermine, RMI 10.393 and Ro 4-4318. Toxicol. appl. Pharmacol. 27, 395–407 (1974)
Lüllmann, H., Lüllmann-Rauch, R., Wassermann, O.: Arzneimittel-induzierte Phospholipidspeicherkrankheit. Dtsch. med. Wschr. 98, 1616–1625 (1973)
Mason, R. J., Huber, G., Vaughan, M.: Synthesis of dipalmitoyl lecithin by alveolar macrophages. J. clin. Invest. 51, 68–73 (1972)
Naimark, A.: Cellular dynamics and lipid metabolism in the lung. Fed. Proc. 32, 1967–1971 (1973)
Naimark, A., Klass, D.: The incorporation of palmitate-1-14C by rat lung in vitro. Canad. J. Physiol. Pharmacol. 45, 597–607 (1967)
Nasr, K., Heinemann, H. O.: Lipid synthesis by rabbit lung tissue in vitro. Amer. J. Physiol. 208, 118–121 (1965)
Newman, D., Naimark, A.: Palmitate-14C uptake by rat lung: effect of altered gas tensions. Amer. J. Physiol. 214, 305–312 (1968)
Rouser, G., Siakotos, A. N., Fleischer, S.: Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1, 85–86 (1966)
Salisbury-Murphy, S., Rubinstein, D., Beck, J. C.: Lipid metabolism in lung slices. Amer. J. Physiol. 211, 988–992 (1966)
Thomas, T., Rhoades, R. A.: Incorporation of palmitate-1-14C into lung tissue and “alveolar” lecithin. Amer. J. Physiol. 219, 1535–1538 (1970)
Wang, M. C., Meng, H. C.: Lipid synthesis by rat lung in vitro. Lipids 7, 207–211 (1972)
Wolfe, B. M., Anhalt, B., Beck, J. C., Rubinstein, D.: Lipid metabolism in rabbit lungs. Canad. J. Biochem. 48, 170–177 (1970)
Young, S. L., Tierney, D. F.: Dipalmitoyl lecithin secretion and metabolism by the rat lung. Amer. J. Physiol. 222, 1539–1544 (1972)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Karabelnik, D., Zbinden, G. Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318. Arch. Toxicol. 35, 163–174 (1976). https://doi.org/10.1007/BF00293563
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00293563
Key words
- Chlorphentermine
- RMI 10.393
- Ro 4-4318
- Drug-induced lipidosis
- Foam cell reaction
- Palmitate-1-14C incorporation and turnover
- Lung phospholipid metabolism